Rigel Pharmaceuticals (NASDAQ: RIGL) has recently received a number of price target changes and ratings updates: 8/25/2026 – Rigel Pharmaceuticals was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”. 8/17/2026 – Rigel Pharmaceuticals had its “neutral” rating reaffirmed by Piper Sandler. They now have a $49.00 price target on the stock, up from […]

A number of firms have modified their ratings and price targets on shares of Inovio Pharmaceuticals (NASDAQ: INO) recently: 8/15/2026 – Inovio Pharmaceuticals was upgraded by Wall Street Zen from “sell” to “hold”. 8/13/2026 – Inovio Pharmaceuticals was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 8/13/2026 – Inovio Pharmaceuticals had its “neutral” […]

A number of research firms have changed their ratings and price targets for Starbucks (NASDAQ: SBUX): 8/18/2026 – Starbucks was given a new $120.00 price target by Needham & Company LLC. 8/18/2026 – Starbucks had its “buy” rating reaffirmed by TD Cowen. 8/3/2026 – Starbucks was downgraded by Wells Fargo & Company from “overweight” to […]